Cleared Traditional

K981931 - CEDIA RED BLOOD CELL FOLATE REAGENT PACK

K981931 is the FDA 510(k) clearance for CEDIA RED BLOOD CELL FOLATE REAGENT PACK by Roche Diagnostics/Boehringer Mannheim GmbH. It is a Class 2 Chemistry device (product code CGN) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K981931 · Roche Diagnostics/Boehringer Mannheim GmbH · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1998
Decision
84d
Days
Class 2
Risk

K981931 is an FDA 510(k) clearance for the CEDIA RED BLOOD CELL FOLATE REAGENT PACK, CEDIA FOLATE ASSAY AND ELECSYS FOLA.... Classified as Acid, Folic, Radioimmunoassay (product code CGN), Class II - Special Controls.

Submitted by Roche Diagnostics/Boehringer Mannheim GmbH (Pleasanton, US). The FDA issued a Cleared decision on August 25, 1998 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1295 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Roche Diagnostics/Boehringer Mannheim GmbH devices

Submission Details

510(k) Number K981931 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 1998
Decision Date August 25, 1998
Days to Decision 84 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 88d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGN Acid, Folic, Radioimmunoassay
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1295
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGN Acid, Folic, Radioimmunoassay

All 51
Devices cleared under the same product code (CGN) and FDA review panel - the closest regulatory comparables to K981931.
AIA-PACK FOLATE ASSAY
K992365 · Tosoh Medics, Inc. · Aug 1999
VITROS IMMUNODIAGNOSTIC PRODUCTS FOLATE REAGENT PACK 1/2, VITROS IMMUNODIAGNOSTIC PRODUCTS VITAMIN B12/FOLATE REAGENT P3
K984166 · Ortho-Clinical Diagnostics, Inc. · Feb 1999
ABBOTT ARCHITECT FOLATE
K984301 · Abbott Laboratories · Feb 1999
ABBOTT AXSYM FOLATE
K972232 · Abbott Laboratories · Jun 1997
AIA-PACK FOLATE ASSAY
K964349 · Tosoh Medics, Inc. · Nov 1996
CEDIA RED BLOOD CELL FOLATE (NO BOIL REAGENT PACK)
K960800 · Boehringer Mannheim Corp. · Jul 1996